High-Flow nasal cannula oxygen therapy reduces postoperative atelectasis in patients undergoing laparoscopic surgery: a randomized, controlled clinical study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047235

Enrollment

Unknown

Registered

2021-06-11

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atelectasis

Interventions

Control group:Traditional nasal catheter oxygen therapy

Experimental group:High-flow nasal cannula oxygen therapy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1.Patients undergoing laparoscopic colorectal cancer surgery; 2.ASA I-III; 3.BMI 18-30kg/m^2.

Exclusion criteria

Exclusion criteria: 1.There were respiratory tract infection with cough, expectoration and other symptoms before operation; 2.Preoperative examination showed atelectasis, pulmonary vesicles and severe chronic obstructive pulmonary disease; 3.Previous lung, mediastinal and cardiac operations.

Design outcomes

Primary

Measure	Time frame
Lung ultrasound scores;	—

Secondary

Measure	Time frame
Incidence of atelectasis;Incidence of pneumonia;	—

Countries

China

Contacts

Public ContactSun Long

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

sun_long2@163.com+86 13162829721

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026